Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
Arthritis Research & Therapy2014Vol. 16(2), pp. R60–R60
Citations Over TimeTop 10% of 2014 papers
Peter E. Lipsky, Leonard H. Calabrese, Arthur Kavanaugh, John S. Sundy, David Wright, Marsha Wolfson, Michael A. Becker
Abstract
NCT00325195. Registered 10 May 2006, NCT01356498. Registered 27 October 2008.
Related Papers
- → The determinants of tumour immunogenicity(2012)422 cited
- An overview of scientific and regulatory issues for the immunogenicity of biological products.(2003)
- → Aggregation and Immunogenicity of Therapeutic Proteins(2010)38 cited
- → Immunogenicity of Therapeutic Proteins(2010)29 cited
- → Immunogenicity(2015)